F/M Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,268
Closed -$205K 360
2026
Q1
$205K Sell
3,268
-43,169
-93% -$3.45M 0.01% 329
2025
Q4
$4.43M Buy
46,437
+28,134
+154% +$2.76M 0.17% 155
2025
Q3
$1.79M Sell
18,303
-1,119
-6% -$116K 0.07% 259
2025
Q2
$2.09M Sell
19,422
-180
-0.9% -$18.2K 0.08% 236
2025
Q1
$1.98M Buy
19,602
+16,144
+467% +$1.63M 0.08% 232
2024
Q4
$309K Sell
3,458
-69,627
-95% -$6.13M 0.01% 355
2024
Q3
$6.12M Sell
73,085
-2,760
-4% -$218K 0.19% 157
2024
Q2
$5.84M Buy
+75,845
New +$5.55M 0.21% 151

Other funds holding BSX

F/M Investments's BSX Position: Q2 2026 in Review

F/M Investments sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,268 shares — an estimated $205K sold.

F/M Investments first reported a position in BSX in Q2 2024 and held it in 8 quarters. The position peaked at $6.12M in Q3 2024. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • F/M Investments reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • F/M Investments sold 3,268 Boston Scientific shares in Q2 2026, an estimated $205K.
  • F/M Investments first reported a position in Boston Scientific in Q2 2024 and held it in 8 quarters.
  • F/M Investments's Boston Scientific position peaked at $6.12M in Q3 2024.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.